986
Views
7
CrossRef citations to date
0
Altmetric
Point of View

Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death

, , & ORCID Icon
Article: e1329072 | Received 05 May 2017, Accepted 08 May 2017, Published online: 20 Jun 2017
 

ABSTRACT

Simultaneous reestablishment of p53/p19Arf and interferon-β pathways in melanoma cells culminates in a cell death process that displays features of necroptosis along with the release of immunogenic cell death molecules and unleashes an antitumor immune response mediated by natural killer cells, neutrophils as well as CD4+ and CD8+ T lymphocytes.

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Funding

We are grateful for the São Paulo Research Foundation for grants (BES) 13/25167–5 and 15/26580–9; and fellowships (RFVM) 13/09474–5, (AH) 11/10656–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.